Literature DB >> 21063846

Clinicopathological features and prognosis of small cell carcinoma of the cervix.

Jie Liu1, Yuan Li, Shuang Li, Dan Wang, Ting Hu, Yuhan Meng, Ding Ma, Hongbing Cai, Zehua Wang, Chengliang Xiong, Huiping Zhang.   

Abstract

Small cell carcinoma of cervix (SCCC) is a rare disease with highly aggressive behaviour and is pathologically hard to diagnose. In this study, the clinicopathological features, diagnosis, treatment and prognosis of the condition were examined. Clinical records and follow-up data of 7 cases of SCCC were retrospectively studied. Our results showed that five non-recurrent cases initially presented irregular vaginal bleeding or increased apocenosis of varying degrees. Pathological examination revealed that the stroma was diffusely infiltrated with small monomorphous cells ranging from round to oval shape. Three cases were immunohistochemically confirmed. One case was accompanied with squamous cell cancer. Of the 7 cases, one case was classified as stage I b1, two stage I b2, one stage IIa, one stage IIb, and one stage IIIb. On the basis of their stages of condition, one subject with stage III b underwent chemotherapy, and one with stage Ib2 received extensive hysterectomy plus pelvic lymphadenectomy, while the other 5 cases were treated by extensive hysterectomy and pelvic lymphadenectomy in combination with pre- and/or post-operative adjuvant chemotherapy and radiotherapy. Of the 7 patients, 4 had relapse-free survival of 14, 14, 16 and 28 months respectively. It is concluded that SCCC is an aggressive tumor with propensity for early pelvis lymph node metastases. Early-stage patients should be treated by extensive hysterectomy and pelvic lymphadenectomy in combination with pre- and/or post-operative adjuvant chemotherapy and radiotherapy.

Entities:  

Mesh:

Year:  2010        PMID: 21063846     DOI: 10.1007/s11596-010-0554-x

Source DB:  PubMed          Journal:  J Huazhong Univ Sci Technolog Med Sci        ISSN: 1672-0733


  17 in total

1.  The molecular biology of neuroendocrine cervical carcinoma: are we witnessing early or late events?

Authors:  C P Crum
Journal:  Gynecol Oncol       Date:  1999-01       Impact factor: 5.482

2.  Comprehensive analysis of p53 gene mutation characteristics in lung carcinoma with special reference to histological subtypes.

Authors:  T Fujita; M Kiyama; Y Tomizawa; T Kohno; J Yokota
Journal:  Int J Oncol       Date:  1999-11       Impact factor: 5.650

3.  CD56 reactivity in small cell carcinoma of the uterine cervix.

Authors:  Jorge Albores-Saavedra; Shahnila Latif; Kelley S Carrick; Isabel Alvarado-Cabrero; Marjorie R Fowler
Journal:  Int J Gynecol Pathol       Date:  2005-04       Impact factor: 2.762

4.  Small cell carcinoma of the cervix. A clinicopathologic study of 26 patients.

Authors:  V M Abeler; R Holm; J M Nesland; K E Kjørstad
Journal:  Cancer       Date:  1994-02-01       Impact factor: 6.860

5.  Small-cell carcinoma of the cervix: fourteen years of experience at a single institution using a combined-modality regimen of involved-field irradiation and platinum-based combination chemotherapy.

Authors:  P J Hoskins; K D Swenerton; J A Pike; P Lim; C Aquino-Parsons; F Wong; N Lee
Journal:  J Clin Oncol       Date:  2003-09-15       Impact factor: 44.544

6.  Small cell neuroendocrine carcinomas of the uterine cervix: a histological, immunohistochemical, and molecular genetic study.

Authors:  Gabriela Mirei Ishida; Noriko Kato; Tadashi Hayasaka; Maki Saito; Hiroshi Kobayashi; Yousei Katayama; Shunichi Sasou; Nobuo Yaegashi; Hirohisa Kurachi; Teiichi Motoyama
Journal:  Int J Gynecol Pathol       Date:  2004-10       Impact factor: 2.762

7.  Small-cell neuroendocrine carcinoma of the cervix. A human papillomavirus type 18-associated cancer.

Authors:  M H Stoler; S E Mills; D J Gersell; A N Walker
Journal:  Am J Surg Pathol       Date:  1991-01       Impact factor: 6.394

8.  Prognostic factors in surgically treated small cell cervical carcinoma followed by adjuvant chemotherapy.

Authors:  T C Chang; C H Lai; C J Tseng; S Hsueh; K G Huang; H H Chou
Journal:  Cancer       Date:  1998-08-15       Impact factor: 6.860

9.  Prognostic factors in neuroendocrine small cell cervical carcinoma: a multivariate analysis.

Authors:  John K Chan; Vera Loizzi; Robert A Burger; Joanne Rutgers; Bradley J Monk
Journal:  Cancer       Date:  2003-02-01       Impact factor: 6.860

10.  Small cell neuroendocrine carcinoma of the cervix: outcome and patterns of recurrence.

Authors:  Akila N Viswanathan; Michael T Deavers; Anuja Jhingran; Pedro T Ramirez; Charles Levenback; Patricia J Eifel
Journal:  Gynecol Oncol       Date:  2004-04       Impact factor: 5.482

View more
  2 in total

1.  Adjuvant chemotherapy, a valuable alternative option in selected patients with cervical cancer.

Authors:  Shuang Li; Ting Hu; Yile Chen; Hang Zhou; Xiong Li; Xiaodong Cheng; Ru Yang; Shixuan Wang; Xing Xie; Ding Ma
Journal:  PLoS One       Date:  2013-09-13       Impact factor: 3.240

2.  Small cell neuroendocrine carcinoma of the uterine cervix presenting with syndrome of inappropriate antidiuretic hormone secretion.

Authors:  Do Young Kim; Hye Jung Yun; Yong Seok Lee; Hae Nam Lee; Chan Joo Kim
Journal:  Obstet Gynecol Sci       Date:  2013-11-15
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.